Formulation containing cyclin-dependent kinase inhibiting compound and method of treating tumors using the same

Details for Australian Patent Application No. 2008301925 (hide)

Owner SCHERING CORPORATION

Inventors Kirschmeier, Paul; Shameem, Mohammed; Antochshuk, Valentyn; Bannerji, Rajat; Statkevich, Paul; Dabbara, Anita; Parry, David A.; Yao, Siu-Long

Agent Griffith Hack

Pub. Number AU-A-2008301925

PCT Pub. Number WO2009/038701

Priority 61/053,784 16.05.08 US; 60/994,185 17.09.07 US; 60/999,469 17.10.07 US

Filing date 16 September 2008

Wipo publication date 26 March 2009

International Classifications

A61K 9/08 (2006.01) Medicinal preparations characterised by special physical form - Solutions

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

A61K 47/12 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Carboxylic acids

Event Publications

1 April 2010 PCT application entered the National Phase

  PCT publication WO2009/038701 Priority application(s): WO2009/038701

4 October 2012 Alteration of Name

  The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008301927-Semi-automatic emergency medication dose nebulizer

2008301921-Polyaxial bone anchor assembly with one-piece closure, pressure insert and plastic elongate member